Facile Incorporation of Carbon Nanotubes into the Concrete Matrix Using Lignosulfonate Surfactants.

One of the ways to turn concrete into smart concrete involves the incorporation of conductive fillers. These fillers should be evenly distributed in the matrix to enable the charge propagation necessary for sensing. To homogenize the mixture, typical surface-active chemical compounds are routinely employed.

(Bio)degradable Biochar Composites of PLA/P(3HB--4HB) Commercial Blend for Sustainable Future-Study on Degradation and Electrostatic Properties.

Interesting alternatives to expensive biodegradable polymers are their composites with natural fillers. The addition of biochar to a blend of poly(lactic acid) (PLA) and poly(3-hydroxybutyrate--4-hydroxybutyrate) was studied, and the resulting materials were evaluated for their properties and changes during degradation. Introducing biochar as a filler brought a noticeable improvement in electrostatic properties.

Cognitive performance of medulloblastoma tumour survivors related to the area of cerebellum damage.

Background: The aim of the study was to determine the relationship between a damaged cerebellum area and the cognitive performance of medulloblastoma tumour survivors. Also, age-based differences in cognitive performance were tested.

Materials And Methods: Magnetic resonance imaging (MRI) technique was used to obtain brain images of survivors.

Quality of life in survivors of childhood brain tumour and the association of children's diseases on quality of their parents life.

Objective: Evaluation of children's quality of life (QoL) after finished brain tumour treatment and the association of children's diseases on quality of their parents' life.

Methods: The study group was consisted of 46 children after brain tumour treatment (aged 4, 5, to 29 years old). The control group was composed of 104 students of primary, secondary, and high schools.

Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas.

Background: Chronic myeloid leukemia (CML) constitutes only 2-3% of all leukemias in pediatric patients. Philapelphia chromosome and BCR-ABL fusion are genetic hallmarks of CML, and their presence is crucial for targeted molecular therapy with tyrosine kinase inhibitors (TKIs), which replaced hematopoietic stem cell transplantation (HSCT) as a standard first-line therapy. The disease in pediatric population is rare, and despite molecular and clinical similarities to CML in adults, different approach is needed, due to the long lifetime expectancy and distinct developmental characteristics of affected children.